Patent · US Active

Methods for treating cancer

US12383534B2 · kind B2 · utility

0Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 7, 2024
Grant dateAug 12, 2025
Priority date
Expiry dateFeb 7, 2044

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for treating a cancer involving one or more translocations generating an oncogenic fusion transcription factor that requires p300/CBP for activity in an animal, comprising administering a compound of formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.